Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-232
Closed -$21.5K 331
2025
Q1
$21.5K Buy
232
+185
+394% +$17.1K ﹤0.01% 744
2024
Q4
$4.27K Hold
47
﹤0.01% 1072
2024
Q3
$4.54K Hold
47
﹤0.01% 1114
2024
Q2
$4.32K Buy
47
+29
+161% +$2.69K ﹤0.01% 1113
2024
Q1
$1.66K Hold
18
﹤0.01% 1251
2023
Q4
$1.71K Buy
+18
New +$1.68K ﹤0.01% 1220

Other funds holding AMED

Quent Capital's AMED Position: Q2 2025 in Review

Quent Capital sold out of Amedisys (AMED) in Q2 2025, closing a stake of 232 shares — an estimated $21.5K sold.

Quent Capital first reported a position in AMED in Q4 2023 and held it in 6 quarters. The position peaked at $21.5K in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Quent Capital reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Quent Capital sold 232 Amedisys shares in Q2 2025, an estimated $21.5K.
  • Quent Capital first reported a position in Amedisys in Q4 2023 and held it in 6 quarters.
  • Quent Capital's Amedisys position peaked at $21.5K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Quent Capital's 13F filing for Q2 2025, filed 21 Jul 2025.